Monday 17 May 2021

Pfizer Covid vaccine blocks 94% of asymptomatic infections and 97% of symptomatic cases in Israeli study

The study also found the vaccine was at least 97% effective against symptomatic Covid cases, hospitalizations and deaths, the company said.

(CNBC) Pfizer said Thursday, March 11, its Covid-19 vaccine blocked 94% of asymptomatic infections in an Israeli study — a result CEO Albert Bourla called “extremely important.”

The study, which measured results two weeks after the second dose, also found the vaccine was at least 97% effective against symptomatic Covid cases, hospitalizations and deaths, according to Pfizer, which developed the shot with BioNTech.

The analysis used data collected between Jan. 17 and March 6, when Pfizer’s vaccine was the only available shot in the country and when the more transmissible B.1.1.7 variant from the U.K. was the dominant strain.

- Advertisement -

“This is extremely important … for society,” Bourla said in an interview with CNBC’s “Squawk Box.” “The asymptomatic carriers and patients are the ones spreading the disease mainly. We were expecting something good in terms of symptomatic,” he said, adding the company was not expecting such a “high number” against asymptomatic cases.

An asymptomatic person is someone who has Covid-19 but doesn’t have any symptoms and never develops them. It’s not the same as a pre-symptomatic patient who later goes on to develop symptoms. At least 50% of transmission is estimated to have occurred from people who don’t have symptoms, according to a study in JAMA published in January.

The Israeli study means the Pfizer vaccine could significantly reduce transmission.

“This clearly demonstrates the power of the COVID-19 vaccine to fight this virus and encourages us to continue even more intensively with our vaccination campaign,” Israel Ministry of Health Director Yeheskel Levy said in a press release. “We aim to achieve even higher uptake in people of all ages, which gives us hope of regaining normal economic and social function in the not so distant future.”

- Advertisement -

Israel launched its national vaccination campaign in December prioritizing people 60 and older, health-care workers, and people with comorbid conditions. By February, it was leading the world in vaccinations, inoculating millions of its citizens against the virus.

In January, Pfizer and the Israel Ministry of Health entered into a collaboration agreement to monitor the real-world impact of its vaccine.

Bourla also said Thursday the company is assessing the impact a booster dose may have on the virus, particularly the B.1.351 strain in South Africa, which he said “seems to be the toughest one.”

“We have very good protection already with two doses,” he said.

- Advertisement -

FACT CHECK:
We strive for accuracy in its reports. But if you see something that doesn’t look right, send us an email. The Q reviews and updates its content regularly to ensure it’s accuracy.

Q Costa Rica
Reports by QCR staff

Related Articles

College of Physicians proposes to apply 150,000 doses weekly; tighten vehicle restrictions

QCOSTARICA - Applying 150,000 doses per week of the covid-19 vaccine...

Coronavirus digest: choice to get ‘vaccinated or infected’

The German health minister, Jens Spahn, said that despite falling daily cases of...

MOST READ

Recope requests the sixth consecutive increase in fuel prices for 2021

QCOSTARICA - The Refinadora Costarricense de Petróleo(RECOPE - the refinery that does not refine anything - requested the sixth consecutive fuel hike in 2021. As...

Guide to the COVID Travel Restrictions for Central America

QCOSTARICA - A country-by-country guide to the current Covid travel restrictions for Central America guidelines during the COVID-19 crisis. Costa Rica (open) Costa Rica opened its...

Q Media supports AmCham initiative to request donation of vaccines to the United States

QCOSTARICA - The Costa Rican North American Chamber of Commerce (AmCham) this week began a Change.org petition to collect signatures to ask the United...

11,773 older adults rejected the covid-19 vaccine; another 441 missed the second dose

QCOSTARICA - A total of 11,773 older adults (defined here as those ages 58 and up) have rejected the covid-19 vaccine and another 441...

Colombia surpasses 80,000 COVID-19 deaths; ICU’s nearly full

QCOLOMBIA – Confirmed deaths from COVID-19 in Colombia passed 80,000 on Friday, May 14, with intensive care units almost full in the biggest cities,...

These are the sanitary measures that will be applied from today, May 10

NOTE: Monday afternoon the government announced changes in the vehicle restrictions that take effect Tuesday, May 11 and capacities (aforos) starting May 13 and...

How to Make the Most Out of Your Travel Experience

There’s no one out there that doesn’t love the sense of adventure that comes with exploring a new place. Whether you’re planning a short...

Health expands group 3 vaccination for people from 16 to 58 years

QCOSTARICA - Adolescents of 16 and 17 years old with some risk factor in case of falling ill with covid-19 will be part of...

San Jose airport how has rapid covid-19 testing for travelers

QCOSTARICA -  Travelers who require a negative covid-19 test to enter their destination country may now get tested at the Juan Santamaría (San Jose)...

WANT TO STAY UP TO DATE WITH THE LATEST!

Get our daily newsletter with the latest posts directly in your mailbox. Click on the subscribe and fill out the form. It's that simple!

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.